Candidate pathway-based genetic association study of platinum and platinum-taxane related toxicity in a cohort of primary lung cancer patients

Journal of the Neurological Sciences

Volumn 349, Issue 1-2, 2015, Pages 124-128

  Johnson, Cassandra ^a   Pankratz, Vernon S ^a   Velazquez, Ana I ^a   Aakre, Jeremiah A ^a   Loprinzi, Charles L ^a   Staff, Nathan P ^a   Windebank, Anthony J ^a   Yang, Ping ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

Chemotherapy induced peripheral neuropathy; Diabetes; Genetic; Paclitaxel; Platinum drugs; Single nucleotide polymorphism

Indexed keywords

CISPLATIN DERIVATIVE; DNA; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 7; GLUTATHIONE TRANSFERASE; ISOENZYME; METHYL O GUANINE METHYL TRANSFERASE; METHYLTRANSFERASE; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 4; RAD51 PROTEIN; RIBONUCLEOSIDE DIPHOSPHATE REDUCTASE; TAXANE DERIVATIVE; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP C PROTEIN; ABCC4 PROTEIN, HUMAN; ANTINEOPLASTIC AGENT; BRIDGED COMPOUND; DNA LIGASE; DNA METHYLTRANSFERASE; GONAD-SPECIFIC TRANSPORTER, HUMAN; GPX7 PROTEIN, HUMAN; MGMT PROTEIN, HUMAN; MULTIDRUG RESISTANCE PROTEIN; ORGANIC ANION TRANSPORTER; PEROXIDASE; PLATINUM; TAXANE; TAXOID; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY; COMORBIDITY; CONTROLLED STUDY; DNA REPAIR; DRUG INDUCED DISEASE; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; HAPLOTYPE; HUMAN; INTRACELLULAR SIGNALING; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEUROTOXICITY; OUTCOME ASSESSMENT; PERIPHERAL NEUROPATHY; PRIMARY TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; ADULT; AGED; CHEMICALLY INDUCED; COHORT ANALYSIS; GENETICS; LUNG NEOPLASMS; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRIDGED COMPOUNDS; COHORT STUDIES; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; ORGANIC ANION TRANSPORTERS; PERIPHERAL NERVOUS SYSTEM DISEASES; PEROXIDASES; PLATINUM; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TAXOIDS; TUMOR SUPPRESSOR PROTEINS;

EID: 84923946894     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2014.12.041     Document Type: Article

References (43)

1. D.M. Gershenson, J.T. Wharton, J. Herson, C.L. Edwards, and F.N. Rutledge Single-agent cis-platinum therapy for advanced ovarian cancer Obstet Gynecol 58 4 1981 487 496
2. Z. Nurgalieva, R. Xia, C.C. Liu, K. Burau, D. Hardy, and X.L. Du Risk of chemotherapy-induced peripheral neuropathy in large population-based cohorts of elderly patients with breast, ovarian, and lung cancer Am J Ther 17 2 2010 148 158
3. A.J. Windebank, and W. Grisold Chemotherapy-induced neuropathy J Peripher Nerv Syst 13 1 2008 27 46
4. S.B. Park, A.V. Krishnan, C.S. Lin, D. Goldstein, M. Friedlander, and M.C. Kiernan Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies Curr Med Chem 15 29 2008 3081 3094
5. G. Cavaletti Peripheral neurotoxicity of platinum-based chemotherapy Nat Rev Cancer 8 1 2008 [1pp. following 71; author reply 1p following]
6. D.R. Pachman, D.L. Barton, J.C. Watson, and C.L. Loprinzi Chemotherapy-induced peripheral neuropathy: prevention and treatment Clin Pharmacol Ther 90 3 2011 377 387
7. G. Cavaletti, C. Minoia, M. Schieppati, and G. Tredici Protective effects of glutathione on cisplatin neurotoxicity in rats Int J Radiat Oncol Biol Phys 29 4 1994 771 776
8. A. Pace, D. Giannarelli, E. Galie, A. Savarese, S. Carpano, and M. Della Giulia Vitamin E neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial Neurology 74 9 2010 762 766
9. C. Pisano, G. Pratesi, D. Laccabue, F. Zunino, P. Lo Giudice, and A. Bellucci Paclitaxel and cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine Clin Cancer Res 9 15 2003 5756 5767
10. J.W. Albers, V. Chaudhry, G. Cavaletti, and R.C. Donehower Interventions for preventing neuropathy caused by cisplatin and related compounds Cochrane Database Syst Rev 2 2011 CD005228
11. A. Dzagnidze, Z. Katsarava, J. Makhalova, B. Liedert, M.S. Yoon, and H. Kaube Repair capacity for platinum-DNA adducts determines the severity of cisplatin-induced peripheral neuropathy J Neurosci 27 35 2007 9451 9457
12. L.E. Ta, L. Espeset, J. Podratz, and A.J. Windebank Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding Neurotoxicology 27 6 2006 992 1002
13. A. Alaedini, Z. Xiang, H. Kim, Y.J. Sung, and N. Latov Up-regulation of apoptosis and regeneration genes in the dorsal root ganglia during cisplatin treatment Exp Neurol 210 2 2008 368 374
14. M.G. Bottone, C. Soldani, P. Veneroni, D. Avella, M. Pisu, and G. Bernocchi Cell proliferation, apoptosis and mitochondrial damage in rat B50 neuronal cells after cisplatin treatment Cell Prolif 41 3 2008 506 520
15. S.J. Fischer, E.S. McDonald, L. Gross, and A.J. Windebank Alterations in cell cycle regulation underlie cisplatin induced apoptosis of dorsal root ganglion neurons in vivo Neurobiol Dis 8 6 2001 1027 1035
16. J.S. Gill, and A.J. Windebank Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle J Clin Invest 101 12 1998 2842 2850
17. E.S. McDonald, K.R. Randon, A. Knight, and A.J. Windebank Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity Neurobiol Dis 18 2 2005 305 313
18. E.S. McDonald, and A.J. Windebank Cisplatin-induced apoptosis of DRG neurons involves bax redistribution and cytochrome c release but not fas receptor signaling Neurobiol Dis 9 2 2002 220 233
19. J.L. Podratz, A.M. Knight, L.E. Ta, N.P. Staff, J.M. Gass, and K. Genelin Cisplatin induced mitochondrial DNA damage in dorsal root ganglion neurons Neurobiol Dis 41 3 2011 661 668
20. N. Barahmani, S. Carpentieri, X.N. Li, T. Wang, Y. Cao, and L. Howe Glutathione S-transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma Neuro Oncol 11 3 2009 292 300
21. Y.C. Chen, C.H. Tzeng, P.M. Chen, J.K. Lin, T.C. Lin, and W.S. Chen Influence of GSTP1 I105V polymorphism on cumulative neuropathy and outcome of FOLFOX-4 treatment in Asian patients with colorectal carcinoma Cancer Sci 101 2 2010 530 535
22. S.R. McWhinney, R.M. Goldberg, and H.L. McLeod Platinum neurotoxicity pharmacogenetics Mol Cancer Ther 8 1 2009 10 16
23. L.P. Martin, T.C. Hamilton, and R.J. Schilder Platinum resistance: the role of DNA repair pathways Clin Cancer Res 14 5 2008 1291 1295
24. A. Scuteri, A. Galimberti, D. Maggioni, M. Ravasi, S. Pasini, and G. Nicolini Role of MAPKs in platinum-induced neuronal apoptosis Neurotoxicology 30 2 2009 312 319
25. J.J. Liu, S.M. Jamieson, J. Subramaniam, V. Ip, N.N. Jong, and J.F. Mercer Neuronal expression of copper transporter 1 in rat dorsal root ganglia: association with platinum neurotoxicity Cancer Chemother Pharmacol 64 4 2009 847 856
26. S.J. Fischer, J.L. Podratz, and A.J. Windebank Nerve growth factor rescue of cisplatin neurotoxicity is mediated through the high affinity receptor: studies in PC12 cells and p75 null mouse dorsal root ganglia Neurosci Lett 308 1 2001 1 4
27. L.E. Ta, A.J. Bieber, S.M. Carlton, C.L. Loprinzi, P.A. Low, and A.J. Windebank Transient receptor potential vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice Mol Pain 6 2010 15
28. Z. Sun, M.C. Aubry, C. Deschamps, R.S. Marks, S.H. Okuno, and B.A. Williams Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: an analysis of 5018 hospital- and 712 population-based cases J Thorac Cardiovasc Surg 131 5 2006 1014 1020
29. P. Yang, M.S. Allen, M.C. Aubry, J.A. Wampfler, R.S. Marks, and E.S. Edell Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003 Chest 128 1 2005 452 462
30. V.S. Pankratz, Z. Sun, J. Aakre, Y. Li, C. Johnson, and Y.I. Garces Systematic evaluation of genetic variants in three biological pathways on patient survival in low-stage non-small cell lung cancer J Thorac Oncol 6 9 2011 1488 1495
31. P. Yang, J.O. Ebbert, Z. Sun, and R.M. Weinshilboum Role of the glutathione metabolic pathway in lung cancer treatment and prognosis: a review J Clin Oncol 24 11 2006 1761 1769
32. Y. Li, Z. Sun, J.M. Cunningham, M.C. Aubry, J.A. Wampfler, and G.A. Croghan Genetic variations in multiple drug action pathways and survival in advanced stage non-small cell lung cancer treated with chemotherapy Clin Cancer Res 17 11 2011 3830 3840
33. U.S. Department of Health and Human Services NIoH, National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE), version 4.0 2010
34. S. Purcell, B. Neale, K. Todd-Brown, L. Thomas, M.A. Ferreira, and D. Bender PLINK: a tool set for whole-genome association and population-based linkage analyses Am J Hum Genet 81 3 2007 559 575
35. P.J. Dyck, K.M. Kratz, J.L. Karnes, W.J. Litchy, R. Klein, and J.M. Pach The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study Neurology 43 4 1993 817 824
36. A.M. Moyer, Z. Sun, A.J. Batzler, L. Li, D.J. Schaid, and P. Yang Glutathione pathway genetic polymorphisms and lung cancer survival after platinum-based chemotherapy Cancer Epidemiol Biomarkers Prev 19 3 2010 811 821
37. Y. Maki, J. Murakami, J. Asaumi, H. Tsujigiwa, H. Nagatsuka, and S. Kokeguchi Role of O6-methylguanine-DNA methyltransferase and effect of O6-benzylguanine on the anti-tumor activity of cis-diaminedichloroplatinum(II) in oral cancer cell lines Oral Oncol 41 10 2005 984 993
38. X.D. Yan, L.Y. Pan, Y. Yuan, J.H. Lang, and N. Mao Identification of platinum-resistance associated proteins through proteomic analysis of human ovarian cancer cells and their platinum-resistant sublines J Proteome Res 6 2 2007 772 780
39. S. Funke, M. Timofeeva, A. Risch, M. Hoffmeister, C. Stegmaier, and C.M. Seiler Genetic polymorphisms in GST genes and survival of colorectal cancer patients treated with chemotherapy Pharmacogenomics 11 1 2010 33 41
40. A. Scuteri, A. Galimberti, M. Ravasi, S. Pasini, E. Donzelli, and G. Cavaletti NGF protects dorsal root ganglion neurons from oxaliplatin by modulating JNK/Sapk and ERK1/2 Neurosci Lett 486 3 2010 141 145
41. R. Schulz, T. Emmrich, H. Lemmerhirt, U. Leffler, K. Sydow, and C. Hirt Identification of a glutathione peroxidase inhibitor that reverses resistance to anticancer drugs in human B-cell lymphoma cell lines Bioorg Med Chem Lett 22 21 2012 6712 6715
42. A.V. Khrunin, A. Moisseev, V. Gorbunova, and S. Limborska Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients Pharmacogenomics J 10 1 2010 54 61
43. J. Oldenburg, S.M. Kraggerud, E.K. Grov, A.A. Dahl, R.A. Lothe, and S.D. Fossa Platinum, polymorphisms, and personality: impact on long-term neurotoxicity J Clin Oncol 26 15S 2008 5036